Renaissance Technologies (RenTech)'s NUVB Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 559,180 shares of Nuvation Bio Inc. (NUVB) worth $2.4 M, representing 0.00% of the portfolio. First purchased in 2021-Q2, this medium-term investment has been held for 19 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in NUVB, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2023, adding 1.09 M shares. Largest reduction occurred in Q1 2024, reducing 508,431 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Nuvation Bio (NUVB) Holding Value Over Time
Track share changes against reported price movement
Quarterly Nuvation Bio (NUVB) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +559,180 | New Buy | 559,180 | $4.29 |
| Q3 2025 | -22,100 | Sold Out | 0 | $0.00 |
| Q2 2025 | -422,000 | Reduce 95.02% | 22,100 | $1.95 |
| Q1 2025 | -122,700 | Reduce 21.65% | 444,100 | $1.76 |
| Q4 2024 | -462,200 | Reduce 44.92% | 566,800 | $2.66 |
| Q3 2024 | +268,000 | Add 35.22% | 1.03 M | $2.29 |
| Q2 2024 | -213,700 | Reduce 21.92% | 761,000 | $2.92 |
| Q1 2024 | -508,431 | Reduce 34.28% | 974,700 | $3.64 |
| Q4 2023 | +1.09 M | Add 280.29% | 1.48 M | $1.51 |
| Q3 2023 | +78,100 | Add 25.04% | 390,000 | $1.34 |
| Q2 2023 | +38,800 | Add 14.21% | 311,900 | $0.00 |
| Q1 2023 | +128,900 | Add 89.39% | 273,100 | $0.00 |
| Q4 2022 | -116,315 | Reduce 44.65% | 144,200 | $0.00 |
| Q3 2022 | +174,215 | Add 201.87% | 260,515 | $2.24 |
| Q2 2022 | -5,900 | Reduce 6.40% | 86,300 | $3.24 |
| Q1 2022 | +42,600 | Add 85.89% | 92,200 | $5.26 |
| Q4 2021 | -800 | Reduce 1.59% | 49,600 | $8.51 |
| Q3 2021 | -416,400 | Reduce 89.20% | 50,400 | $9.94 |
| Q2 2021 | +466,800 | New Buy | 466,800 | $9.31 |
Renaissance Technologies (RenTech)'s Nuvation Bio Investment FAQs
Renaissance Technologies (RenTech) first purchased Nuvation Bio Inc. (NUVB) in Q2 2021, acquiring 466,800 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Nuvation Bio Inc. (NUVB) for 19 quarters since Q2 2021.
Renaissance Technologies (RenTech)'s largest addition to Nuvation Bio Inc. (NUVB) was in Q4 2023, adding 1,483,131 shares worth $2.24 M.
According to the latest 13F filing for Q1 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 559,180 shares of Nuvation Bio Inc. (NUVB), valued at approximately $2.4 M.
As of the Q1 2026 filing, Nuvation Bio Inc. (NUVB) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Nuvation Bio Inc. (NUVB) was 1,483,131 shares, as reported at the end of Q4 2023.